Health-data specialists at universities and research institutes in Indianapolis expect the virus to hit its peak between mid-April and early May, packing a punch that could cause about 800 new positive COVID-19 cases a day.
Some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.
Indiana University Health said admissions of COVID-19 patients at its 16 hospitals have been “pretty flat” over the past six or seven days, but it’s unclear whether the surge has peaked.
The roster of potential therapies includes new antivirals, older antivirals, anti-inflammatory drugs, stem cell therapies, antiparasitic drugs, and even treatments for erectile dysfunction.
Even as governors, mayors and the federal government urge or require Americans to wear masks in stores, transit systems and other public spaces to contain the spread of the novel coronavirus, the nation is divided about whether to comply.
Increasingly, doctors are reporting bizarre, unsettling cases that don’t seem to follow any of the textbooks they’ve trained on. The concern is so acute some doctor groups have raised the controversial possibility of giving preventive blood thinners to everyone with COVID-19.
The Indianapolis-based drugmaker, which reported quarterly earnings Thursday, warned it could feel the effects of rising unemployment, a decrease in new prescriptions, and downward pricing pressure from government health care systems.
Woody Myers, a former state health commissioner and Anthem Inc. executive, said he thinks the state needs to ramp up testing significantly before considering re-opening the economy.
Steve Wasick has created artificial intelligence-driven story-writing software that CBS Sports, IU Health and the Chicago Mercantile Exchange are using.
To overcome this crisis, we need to balance regulations that protect Indiana’s health with the freedom of private individuals to develop indispensable solutions.
Dr. Cole Beeler knows people are itching to get back to business and resume their normal lives. But he warns employers and workers not to rush back to the old way of doing business, at least not all at once.
Across Indiana, local health departments have been scrambling to keep up with the job of tracking, one patient at a time, the spread of the virus that has already claimed the lives of more than 900 Hoosiers.
The FDA acted after preliminary results from a government-sponsored study showed that the drug, remdesivir, shortened the time to recovery by 31%, or about four days on average, for hospitalized COVID-19 patients.
A survey by the Indiana State Medical Association highlights two impacts from the pandemic and the related shutdown efforts: One to the financial condition of medical practices and one to public health if non-COVID 19 patients continue to delay treatment.
